or Try an Advanced Search...

    Technical Analysis for QNRX - Quoin Pharmaceuticals, Ltd.

    Grade Last Price % Change Price Change
    F 0.59 2.02% 0.01
    QNRX closed up 2.02 percent on Monday, July 1, 2024, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical QNRX trend table...
    Date Alert Name Type % Chg
    Stochastic Buy Signal Bullish 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Doji - Bullish? Reversal 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish 2.02%
    Narrow Range Bar Range Contraction 2.02%
    Wide Bands Range Expansion 2.02%
    Gapped Up Strength 2.02%
    Oversold Stochastic Weakness 2.02%
    Older End-of-Day Signals for QNRX ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 7 hours ago
    Reversed from Up about 8 hours ago
    1.5x Volume Pace about 10 hours ago
    Gap Up Closed about 10 hours ago
    Up 3% about 10 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    QNRX Chart by TradingView
    Basic chart:

    Profile

    Founded in 2018 as Quoin Pharmaceuticals Inc. by Michael Myers Ph.D. and Denise Carter, Quoin is an emerging specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. We are committed to addressing unmet medical needs for patients, their families, communities and care teams. Quoin’s innovative pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa and others.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Clinical Medicine Pharmaceutical Therapeutic Products Genodermatoses Epidermolysis Bullosa Netherton Syndrome Rare And Orphan Diseases

    Is QNRX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 27 Quoin Pharmaceuticals Announces International Expansion of Ongoing Clinical Trials for Netherton Syndrome
    Jun 25 Quoin Pharmaceuticals to Sponsor the Foundation for Ichthyosis & Related Skin Types (FIRST) 2024 National Conference
    Jun 12 Quoin Pharmaceuticals Announces Signing of Research Agreement with University College Cork (UCC), Ireland
    May 22 QNRX: Protocol Modifications Potentially Accelerate, Expand QRX003 Approvals
    May 9 Quoin Pharmaceuticals Non-GAAP EPS of -$1.11 misses by $0.70
    May 9 Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2024 Financial Results
    May 2 Quoin Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 9, 2024
    Mar 15 Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) Q4 2023 Earnings Call Transcript
    Mar 14 Quoin Pharmaceuticals, Ltd. (QNRX) Q4 2023 Earnings Call Transcript
    Mar 13 Quoin Pharmaceuticals GAAP EPS of -$2.08
    See more QNRX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 83.52
    52 Week Low 0.58
    Average Volume 53,410
    200-Day Moving Average 2.77
    50-Day Moving Average 0.70
    20-Day Moving Average 0.66
    10-Day Moving Average 0.60
    Average True Range 0.04
    RSI (14) 31.97
    ADX 20.67
    +DI 12.18
    -DI 23.80
    Chandelier Exit (Long, 3 ATRs) 0.66
    Chandelier Exit (Short, 3 ATRs) 0.71
    Upper Bollinger Bands 0.79
    Lower Bollinger Band 0.54
    Percent B (%b) 0.21
    BandWidth 37.86
    MACD Line -0.05
    MACD Signal Line -0.04
    MACD Histogram -0.005
    Fundamentals Value
    Market Cap 584.14 Thousand
    Num Shares 987 Thousand
    EPS 1.38
    Price-to-Earnings (P/E) Ratio 0.43
    Price-to-Sales 0.00
    Price-to-Book 0.45
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.62
    Resistance 3 (R3) 0.62 0.61 0.62
    Resistance 2 (R2) 0.61 0.60 0.61 0.62
    Resistance 1 (R1) 0.60 0.60 0.61 0.60 0.61
    Pivot Point 0.59 0.59 0.59 0.59 0.59
    Support 1 (S1) 0.58 0.58 0.59 0.58 0.57
    Support 2 (S2) 0.57 0.58 0.57 0.57
    Support 3 (S3) 0.56 0.57 0.57
    Support 4 (S4) 0.56